Advertisement
Advertisement
Trending on Pharmacy Times
1
Apnimed Submits NDA for AD109 Following Positive Phase 3 Results in Obstructive Sleep Apnea
2
Early IVIG Use Associated With Reduced Infections and Improved Survival in Patients Receiving Talquetamab for Multiple Myeloma
3
GIRE Combination Shows PFS Benefit in First-Line Metastatic Breast Cancer Treatment, Earning FDA Priority Review
4
FDA Grants Priority Review to Bezuclastinib Plus Sunitinib for Patients With Advanced GIST
5